Categories
All
Biotech
Clinical Trials
Health Tech
News
Pharma
Regulatory
Investor Trends and Valuation Shifts in the Volatile Biotech Sector
Must-Track Biomarkers
Gene and RNA Therapies Gain Momentum in Obesity Treatment
How Neurons Help Cancer Spread
Astatine-211: The Alpha-Emitter Gaining Momentum in Targeted Radiotherapy
Life Science Development in Singapore: A Rising Global Powerhouse
Life Science Daily News: Join the Community
Halozyme Granted Injunction Against Merck in Keytruda Patent Case
Pharma 5.0: The Future of Human-Centric, Intelligent, Sustainable Medicine
Pharvaris Announces Positive Phase 3 Results for Deucrictibant
AI & Cloud Enabled R&D and Clinical Operations Surge in Life Sciences
Autolus CAR-T Offers Hope to Adults with Aggressive Blood Cancer
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
How the UK May Be Undervaluing Life Sciences Manufacturing Investments
UK Crown Estate Buys Harwell East, Opening 4.5m sq ft for Science & Innovation
Amazon to Launch Prescription Kiosks in LA One Medical Clinics
Blood Test for 50+ Cancers Shows Promise in Faster Diagnosis
Eli Lilly Expands U.S. Manufacturing with Multi-Billion Investment
Trump’s Recent Guidance on Tylenol, Vaccines, and Children Draws Fire from Medical Community
7,000 Steps a Day May Improve Brain and Reduce Disease Risk
NHS Leads Global Rollout of Groundbreaking ‘Trojan Horse’ Blood Cancer Treatment
Chinese Biotech Industry Shows No Signs of Slowing
How the UK May Be Undervaluing Life Sciences Manufacturing Investments
Emerging Drug Therapies in the Fight Against Sarcopenia
Trump’s Proposed Drug Tariff Could Reshape the UK Pharma Landscape
Sustainable and Green Manufacturing Practices in the Life Sciences Industry
Genentech Cuts 87 Jobs in Latest Round of Layoffs at South San Francisco HQ
Navigating Life with Haemophilia with Pfizer
Merck Abandons £1bn UK Expansion, Citing Insufficient Government Support
FDA Picks George Tidmarsh as Head of Drug Regulation Division
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.